General Information
Altimmune Obesity/Fatty Liver 105
A Phase 1, 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of ALT-801 in Non-Diabetic Overweight and Obese Subjects with Non-alcoholic Fatty Liver Disease
| Protocol | ALT-801-105 |
|---|---|
| Identifier | |
| UID | a45d699d-adff-44bb-9ea3-33cb75621912 |
| Status | Done - Archived |
| Phase | 1 |
| Category | Obesity / Adult |
| Launch Year | 2021 |
| NCT Number | - |
| Created | 2021-07-14 12:51 |
| Last Updated | 2023-01-17 23:15 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2022-03-23 | No |
| Enrollment Open | 2021-11-16 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2021-11-03 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2023-01-12 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | Miss, Salomon | SMiss | No |
| Coordinator | Gallardo, Michael | MGallardo | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Altimmune, Inc. |
|---|---|
| Division | Altimmune, Inc. |
| Team | Altimmune, Inc. |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | ProSciento, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
